Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

AVITA Medical, Inc. (RCEL) Profit Margins

Over the twelve months to 2026-06-30, AVITA Medical, Inc. (RCEL) had gross margin 81.6%, operating margin -46.6%, net margin -57.0%, free cash flow margin -33.4%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RCELAVITA Medical, Inc.Follow RCEL — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
479.7M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2020
Jun 20
FY2021
Jun 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin79.2%79.6%82.4%84.5%85.8%82.1%81.6%
Operating margin-299.2%-90.8%-79.9%-85.1%-88.1%-59.4%-46.6%
Net margin-294.7%-90.9%-77.5%-70.6%-96.3%-67.8%-57.0%
FCF margin-163.6%-91.7%-56.8%-78.6%-90.4%-45.9%-33.4%

USD millions · SEC XBRL

AVITA Medical, Inc. — questions

What is AVITA Medical, Inc.'s gross margin?
81.6% over the twelve months to 2026-06-30.
What is AVITA Medical, Inc.'s operating margin?
-46.6% over the twelve months to 2026-06-30.
What is AVITA Medical, Inc.'s net profit margin?
-57.0% over the twelve months to 2026-06-30.

Every figure on this page comes from AVITA Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.